tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GB:0RA9 Stock Latest News

Abivax Reports Share Capital and Voting Rights
Company AnnouncementsAbivax Reports Share Capital and Voting Rights
13h ago
Abivax management to meet virtually with Piper Sandler
PremiumThe Fly
Abivax management to meet virtually with Piper Sandler
8d ago
ABVX
Abivax presents first-half 2024 financial results
PremiumPress Releases
Abivax presents first-half 2024 financial results
10d ago
ABVX
Abivax Reports Share Capital and Voting Rights
PremiumCompany Announcements
Abivax Reports Share Capital and Voting Rights
21d ago
Abivax SA’s Ulcerative Colitis Drug On Track for 2025
PremiumCompany Announcements
Abivax SA’s Ulcerative Colitis Drug On Track for 2025
1M ago
Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
PremiumPress ReleasesAbivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
1M ago
ABVX
Alphabet upgraded, Arm downgraded: Wall Street’s top analyst calls
Premium
The Fly
Alphabet upgraded, Arm downgraded: Wall Street’s top analyst calls
2M ago
GD
ARM
Abivax initiated with a Buy at Laidlaw
Premium
The Fly
Abivax initiated with a Buy at Laidlaw
2M ago
ABVX
Abivax Progresses on Ulcerative Colitis Phase 3 Trial
PremiumCompany Announcements
Abivax Progresses on Ulcerative Colitis Phase 3 Trial
2M ago
Abivax Provides Operational and Key Program Update
PremiumPress Releases
Abivax Provides Operational and Key Program Update
2M ago
ABVX
Abivax Announces Share Capital and Voting Rights
PremiumCompany Announcements
Abivax Announces Share Capital and Voting Rights
3M ago
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
PremiumPress Releases
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
4M ago
ABVX
Abivax Reports Share Capital and Voting Rights
PremiumCompany AnnouncementsAbivax Reports Share Capital and Voting Rights
4M ago
Abivax initiated with a Buy at BTIG
Premium
The Fly
Abivax initiated with a Buy at BTIG
4M ago
ABVX
Apple upgraded, Tesla downgraded: Wall Street’s top analyst calls
Premium
The Fly
Apple upgraded, Tesla downgraded: Wall Street’s top analyst calls
5M ago
T
GD
Abivax initiated with a Buy at Guggenheim on obefazimod’s potential
PremiumThe Fly
Abivax initiated with a Buy at Guggenheim on obefazimod’s potential
5M ago
ABVX
Abivax initiated with a Buy at Guggenheim
PremiumThe Fly
Abivax initiated with a Buy at Guggenheim
5M ago
ABVX
Correction: Abivax was not initiated at Benchmark
PremiumThe Fly
Correction: Abivax was not initiated at Benchmark
5M ago
ABVX
Piper starts Abivax at Overweight on leadership potential in IBD
PremiumThe Fly
Piper starts Abivax at Overweight on leadership potential in IBD
5M ago
ABVX
Abivax initiated with an Overweight at Piper Sandler
PremiumThe FlyAbivax initiated with an Overweight at Piper Sandler
5M ago
ABVX
Abivax price target raised to $16 from $15 at Morgan Stanley
Premium
The Fly
Abivax price target raised to $16 from $15 at Morgan Stanley
5M ago
ABVX
Abivax initiated with an Outperform at Leerink
Premium
The Fly
Abivax initiated with an Outperform at Leerink
10M ago
ABVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >